Biotechnology - Management


Current filters:


Popular Filters

1 to 25 of 43 results

NicOx launches commercial operations in Germany


Ophthalmology-focused French biotech firm NicOx has today announced the launch of its German operations.

AdenoPlusBiotechnologyGermanyManagementMarkets & MarketingNicOxOphthalmicsXailin

Affymax decides to wind up company following demise of Omontys

Affymax decides to wind up company following demise of Omontys


USA-based biotech firm Affymax says that its board of directors has approved the liquidation and dissolution…

AffymaxBiotechnologyFinancialManagementOmontysOncologyTakeda Pharmaceutical

ThromboGenics plans to remain independent


In response to market rumors, Belgian biotech firm ThromboGenics today issues an update on the Strategic…


Big pharma becomes a smaller employer while biotech booms

Big pharma becomes a smaller employer while biotech booms


Big pharma employment dropped by 3% in the decade 2003-2013, allaying fears that industry consolidation…


Dendreon chief to step down for personal reasons

Dendreon chief to step down for personal reasons


US biotech firm Dendreon revealed last evening that John Johnson plans to step down as president and…


Biota Pharma plans restructuring following loss of BARDA contract


USA-based Biota Pharmaceuticals has adopted a plan to restructure the company's operations following…

Anti-viralsBiota PharmaceuticalsBiotechnologyFinanciallaninamivirManagementUSA

China Summit paves the way for Australian companies, says AusBiotech

China Summit paves the way for Australian companies, says AusBiotech


Recognizing the leading role China will take globally in the future of life sciences, trade group AusBiotech…


Merck names Simon Sturge as new head of biosimilars unit

Merck names Simon Sturge as new head of biosimilars unit


Germany’s Merck KGaA has appointed Simon Sturge to head the biosimilars unit, effective March 1, succeeding…

BiosimilarsBiotechnologyBoardroomManagementMerck KGaA

Domain Therapeutics opens North American subsidiary


French biopharma company Domain Therapeutics, specializing in the R&D of new drug candidates targeting…

BiotechnologyCanadaDomain TherapeuticsManagementNorth America

Agilis Biotherapeutics and Intrexon collaborate on rare genetic disease


US synthetic biology companies Agilis Biotherapeutics and Intrexon have entered an exclusive channel…

Agilis BiotherapeuticsBiotechnologyBoardroomFinancialIntrexonManagementRare diseasesResearch

AVEO Oncology restructuring and job cuts as tivozanib future in RCC in doubt


Following a recent negative opinion on its lead product candidate from a Food and Drug Administration…

Astellas PharmaAVEO OncologyBiotechnologyFinancialManagementOncologyResearchtivozanib

Exec appointments at Biogen Idec and Halozyme; Succession plan for Forest Labs


US biotech firm Biogen Idec (Nasdaq: BIIB) announced that Spyros Artavanis-Tsakonas, has been named chief…

Biogen IdecBiotechnologyForest LaboratoriesHalozyme TherapeuticsManagementPharmaceutical

US Senate confirms appointment of Marilyn Tavenner as CMS Administrator


US Health and Human Services (HHS) Secretary Kathleen Sebelius announced that the US Senate has confirmed…

BiotechnologyGenericsHealthcareManagementNorth AmericaPharmaceutical

Aastrom Biosciences to re-focus on DCM program, and cut workforce


US cardiovascular drug developer Aastrom Biosciences (NasdaqCM: ASTM) has announced a strategic change…

Aastrom BiosciencesBiotechnologyCardio-vascularixmyelocel-TManagementResearch

Affymax slashes workforce following Omontys problems; evaluating options


US biopharma company Affymax (Nasdaq: AFFY) says that it will reduce its workforce as part of a plan…


CoCo Therapeutics created in UK to progress retinoic acid receptor alpha agonist for Alzheimer's


King's College London, The Wellcome Trust and Advent Venture Partners have announced the formation of…

BiotechnologyCoCo TherapeuticsFinancialManagementResearch

Roche granted EU approval for Perjeta; board appointments


The European Medicines Agency has approved Swiss drug major Roche's (ROG: SIX) Perjeta (pertuzumab) for…


New US Federal Trade Commission chairman - Edith Ramirez - to be designated by President


President Barack Obama intends to designate Edith Ramirez as Chairman of the Federal Trade Commission…

BiotechnologyGenericsManagementNorth AmericaPharmaceuticalRegulation

Biopharma facing hiring difficulties and R&D talent gap, PwC unit finds


A talent gap in the scientific workforce has biopharmaceutical companies searching outside for fresh…

BiotechnologyManagementNorth AmericaPharmaceuticalResearch

BioCryst Pharma restructures in face of pipeline disappointments


USA-based BioCryst Pharmaceuticals (Nasdaq: BCRX), whose merger with Presidio was called off earlier…

BCX4161BCX5191BioCryst PharmaceuticalsBiotechnologyFinancialManagementperamivirResearchulodesine

Drugmakers spend an average $237,000 per medical science liaison in the USA


US-based drug companies spend an average $237,000 on each of their medical science liaisons (MSLs), but…

BiotechnologyGlobalManagementMarkets & MarketingPharmaceutical

The way forward in health care, by Gilbert Mertens


Preparing for a future of unseen opportunity in health care requires a profound shift in thinking from…


1 to 25 of 43 results

Back to top